Spire Healthcare Group PLC Preliminary Results Presentation -- Change of Venue (3253P)
09 Febrero 2023 - 1:00AM
UK Regulatory
TIDMSPI
RNS Number : 3253P
Spire Healthcare Group PLC
09 February 2023
Spire Healthcare Group plc
('Spire Healthcare', 'the Company' or 'the Group')
Preliminary Results Presentation - Change of Venue
9 February 2023
Further to the Notice of Preliminary Results published on 23
January 2023, the Company announces that the results presentation
will now be held at the offices of Instinctif Partners, 65 Gresham
Street, London, EC2V 7NQ. Amended details are shown below.
Spire Healthcare Group plc (LSE: SPI), a leading independent
healthcare group in the UK, will announce its preliminary results
for the year ended 31 December 2022 on Thursday, 2 March 2023.
An in-person results presentation for sell-side analysts and
investors will be held at 9.00am GMT on 2 March at the offices of
Instinctif Partners, 65 Gresham Street, London, EC2V 7NQ.
Refreshments will be available from 8.30am. If you wish to attend
the presentation, please contact Instinctif Partners at
spire@instinctif.com .
For those unable to attend the in-person presentation, a live
Zoom webinar will be available. Click the following link to
register for the Zoom webinar and to receive access details:
https://spirehealthcare.zoom.us/webinar/register/WN_uSJ3csEcRtWRHIj3nSg2ag
- Ends -
For further information please contact:
Spire Healthcare
Angus Prentice - Director of Investor Relations +44 (0)7974 982 512
Instinctif Partners
Damian Reece +44 (0)7931 598 593
Guy Scarborough +44 (0)7917 178 920
Registered Office and Head Office:
Spire Healthcare Group plc
3 Dorset Rise
London
EC4Y 8EN
Registered number 09084066
About Spire Healthcare
Spire Healthcare is a leading independent healthcare group in
the United Kingdom, with 39 hospitals across England, Wales and
Scotland. It operates a network of private GPs and provides
occupational health services to over 700 corporate clients.
Working in partnership with around 8,150 experienced
consultants, Spire Healthcare delivered tailored, personalised care
to almost 870,000 in-patients, out-patients and day-case patients
in 2021, and is the leading private provider, by volume, of knee
and hip operations in the United Kingdom. The Group's well-located
and scalable hospitals have delivered successful and award-winning
clinical outcomes, positioning the Group well with patients,
consultants, the NHS, GPs and Private Medical Insurance ("PMI")
providers. 98% of Spire Healthcare's inspected hospitals and
clinics are rated 'Good', 'Outstanding' or the equivalent by health
inspectors in England, Wales and Scotland.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NORTPMMTMTIMBRJ
(END) Dow Jones Newswires
February 09, 2023 02:00 ET (07:00 GMT)
Spire Healthcare (LSE:SPI)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Spire Healthcare (LSE:SPI)
Gráfica de Acción Histórica
De May 2023 a May 2024